文献速递神经介入MRDSA

未破裂颅内动脉瘤血管内治疗后新发脑微出血的相关因素

Factors associated with the new appearance of cerebral microbleeds after endovascular treatment for unruptured intracranial aneurysms.
PubMed 文献 · Neuroradiology · 2021-01-07

回顾性分析2016年4月至2018年2月接受血管内治疗的未破裂颅内动脉瘤患者,101个动脉瘤中38个(37.6%)出现新发脑微出血。多因素分析显示慢性肾病、术前脑微出血数量多及术后第1天弥散加权成像阳性病灶数量多是独立危险因素,且增加的脑微出血多位于术后1个月内治疗血管灌注区的皮质和皮质下。

要点

  • 血管内治疗未破裂颅内动脉瘤后37.6%(38/101)出现新发脑微出血。
  • 慢性肾病、术前脑微出血多、术后第1天DWI阳性病灶多是独立危险因素。
  • 新发脑微出血多位于术后1个月内治疗血管灌注区的皮质和皮质下。

关键影像表现/征象

  • 新发脑微出血表现为术后T2*加权MRI上新出现的低信号病灶。
  • 增加的脑微出血较多位于术后1个月内治疗血管灌注区的皮质和皮质下病灶。

诊断标准与关键数值

  • 101个动脉瘤中38个(37.6%)出现新发脑微出血。
  • 多因素分析显示慢性肾病、术前脑微出血数量较多、术后第1天弥散加权成像阳性病灶数量较多为脑微出血增加的独立危险因素。

临床应用与阅片要点

  • 对术前存在小血管病(如慢性肾病、术前脑微出血)的患者,血管内治疗前后应关注T2*加权MRI上脑微出血的新发或增多。
  • 术后第1天弥散加权成像阳性病灶数量较多的患者,需注意随访中脑微出血增加的可能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Endovascular treatment of unruptured intracranial aneurysms may increase cerebral microbleeds (CMBs) in postprocedural T2*-weighted MRIs, which may be a risk for future intracerebral hemorrhage. This study examined the characteristics of postprocedural CMBs and the factors that cause their increase.

METHODS: The patients who underwent endovascular treatment for unruptured intracranial aneurysms from April 2016 to February 2018 were retrospectively analyzed. Treatment techniques for endovascular treatment included simple coiling, balloon-assisted coiling, stent-assisted coiling, or flow diverter placement. To evaluate the increase in CMBs, a head MRI including diffusion-weighted imaging and T2*-weighted MRIs was performed on the preprocedural day; the first postprocedural day; and at 1, 3, and 6 months after the procedure.

RESULTS: Among the 101 aneurysms that were analyzed, 38 (37.6%) showed the appearance of new CMBs. In the multivariate analysis examining the causes of the CMB increases, chronic kidney disease, a higher number of preprocedural CMBs, and a higher number of diffusion-weighted imaging-positive lesions on the first postprocedural day were independent risk factors. Furthermore, a greater portion of the increased CMBs was found in cortical and subcortical lesions of the treated vascular perfusion area within 1 month after the procedure.

CONCLUSION: In endovascular treatment for unruptured intracranial aneurysms, CMBs tended to increase in patients with small vessel disease before the procedure, and it was also implicated in hemorrhagic changes after periprocedural microinfarction.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Higashi E, Hatano T, Ando M, et al. Factors associated with the new appearance of cerebral microbleeds after endovascular treatment for unruptured intracranial aneurysms. Neuroradiology. 2021. PMID: 33410949. doi:10.1007/s00234-020-02616-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。